Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)

Status Completed

Clinical Trial Summary

The purpose of this research study is investigate a new and validated urine test which predicts the likelihood of high grade prostate cancer on an initial prostate biopsy The current protocol has two objectives; one is to further assess and evaluate the performance of the urine test in men already scheduled for initial prostate needle biopsy (cohort (group) 1) and two, to evaluate how the results of the urine test influences the decision process for determining whether to perform a prostate biopsy (cohort (group) 2).

Clinical Trial Description

Primary Objective(s) - Confirm performance of the ExoDx Prostate (IntelliScore) (EPI) utilizing a designated collection vessel for men presenting for their initial prostate biopsy with an elevated Prostate-specific antigen (2-10 ng/mL). - Evaluate impact of the confirmed ExoDx Prostate (IntelliScore) on the decision to perform an initial prostate biopsy for men presenting with an elevated Prostate-specific antigen (2-10 ng/mL). Secondary and Exploratory Objectives - Assess physician satisfaction with the ExoIntelliScore Prostate report including test result presentation, graphics and interpretation. - Assess patient satisfaction for ease of understanding test results and role on decision process to have a biopsy. - Determine the medical economic impact of the ExoIntelliScore Prostate in the prostate biopsy decision process. - Correlation of the ExoIntelliScore Prostate score with the actual biopsy result. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03031418
Study type	Observational
Source	Exosome Diagnostics, Inc.
Contact
Status	Completed
Phase
Start date	September 1, 2016
Completion date	September 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT05191017` - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC	Phase 1/Phase 2
Completed	`NCT00970203` - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer	Phase 2
Completed	`NCT01639859` - Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci	N/A
Completed	`NCT02362464` - Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139	Phase 2
Enrolling by invitation	`NCT05844761` - Real-time Motion Management During Prostate and Lung Radiotherapy	N/A
Completed	`NCT03442075` - Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Recruiting	`NCT05252390` - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT03896958` - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed	`NCT03444532` - Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia	N/A
Recruiting	`NCT05600400` - Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer	N/A
Not yet recruiting	`NCT05653063` - ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Completed	`NCT02235142` - Prostatic Cancer Versus Androgen Deficiency	N/A
Recruiting	`NCT06318559` - Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention	N/A
Completed	`NCT01477749` - Sipuleucel-T Manufacturing Demonstration Study	Phase 2
Active, not recruiting	`NCT03632980` - Dynamic Focusing Evaluation for Prostate Cancer Treatment	N/A
Recruiting	`NCT04319783` - Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA	Phase 2
Recruiting	`NCT04258813` - Onco-primary Care Networking to Support TEAM-based Care	N/A
Recruiting	`NCT05361798` - T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy	Phase 2
Completed	`NCT04304196` - Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgramme	N/A
Completed	`NCT02564120` - North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)